MedPath

levocetirizine dihydrochloride

These highlights do not include all the information needed to use LEVOCETIRIZINE DIHYDROCHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for LEVOCETIRIZINE DIHYDROCHLORIDE ORAL SOLUTION. LEVOCETIRIZINE DIHYDROCHLORIDE oral solutionInitial U.S. Approval: 1995

Approved
Approval ID

a9e7152c-0aa3-4355-8805-307e510ac86b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 26, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levocetirizine dihydrochloride

PRODUCT DETAILS

NDC Product Code72162-1424
Application NumberANDA091263
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateSeptember 26, 2023
Generic NameLevocetirizine dihydrochloride

INGREDIENTS (9)

SODIUM ACETATEInactive
Code: 4550K0SC9B
Classification: IACT
LEVOCETIRIZINE DIHYDROCHLORIDEActive
Quantity: 0.5 mg in 1 mL
Code: SOD6A38AGA
Classification: ACTIB
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
MALTITOLInactive
Code: D65DG142WK
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
SACCHARINInactive
Code: FST467XS7D
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

levocetirizine dihydrochloride - FDA Drug Approval Details